Impact of Bariatric Surgery on Serum Urate Levels in Obese Patients

Overview

This observational study of 283 obese patients undergoing bariatric surgery demonstrated significant reductions in serum urate concentrations sustained up to 24 months postoperatively. Patients with elevated baseline urate levels showed rapid decreases by 4 months, while those with diabetes experienced smaller but significant reductions.

Background

Obesity is a known risk factor for hyperuricemia, which can lead to gout and other comorbidities such as renal and cardiovascular diseases. Weight loss effectively lowers serum urate levels, reducing gout incidence. Bariatric surgery is the most effective long-term weight loss intervention but has been associated with transient postoperative increases in urate and gout attacks in some studies. This study aimed to clarify the longitudinal effects of bariatric surgery on serum urate levels in a larger cohort.

Data Highlights

Key Findings

• Significant weight loss occurred over 24 months post-bariatric surgery, with mean BMI decreasing from 51.1 to lower levels.
• Serum urate levels remained stable at 4 months but significantly decreased at 12 and 24 months compared to baseline (p < 0.001).
• Patients with baseline hyperuricemia (above sex-specific cut-offs) showed rapid urate reductions by 4 months, significant in women.
• Patients without elevated baseline urate had no significant change at 4 months but showed reductions from 12 months onward.
• Patients with diabetes had smaller but still significant reductions in serum urate compared to non-diabetic patients.
• Initial postoperative period did not show increased urate levels overall, contrasting prior smaller studies.

Clinical Implications

Bariatric surgery should be considered an effective intervention to reduce serum urate levels and potentially lower gout risk in obese patients, including those with diabetes. Clinicians should monitor urate levels longitudinally, recognizing that reductions may be delayed in patients with normal baseline urate. Awareness of transient postoperative urate fluctuations remains important for early postoperative management.

Conclusion

Bariatric surgery leads to sustained reductions in serum urate concentrations over 24 months in obese patients, with the greatest and earliest effects seen in those with elevated baseline urate. These findings support bariatric surgery as a beneficial strategy for managing hyperuricemia and related comorbidities in obesity.

References

1. Obesity and hyperuricemia risk [1,2]
2. Hyperuricemia causes gout and renal disease [3,4,5,6]
3. Weight loss reduces serum urate [7,8]
4. Bariatric surgery reduces metabolic diseases [9,10]
5. Postoperative urate increase and gout attacks [11,12]
6. Study cohort and methods [13]
7. Insulin resistance and urate clearance [3,5]
8. Meta-analysis on starvation and hyperuricemia [15]
9. Renal function impact on urate post-surgery [16,17]
10. Previous studies on urate reduction post-bariatric surgery [18,19,20]